Hearing Loss clinical trials at UCLA
2 in progress, 1 open to eligible people
DB-OTO, an AAV Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations
open to eligible people ages up to 17 years
This is a first-in-human, multicenter, Phase 1/2, open-label, 2-part trial with a single-ascending dose patient cohort (Part A) and a bilateral expansion patient cohort (Part B) to evaluate the safety, tolerability, and preliminary efficacy of DB-OTO, an AAV based gene therapy in pediatric patients with biallelic OTOF mutations
Los Angeles, California and other locations
Cochlear Implant With Dexamethasone Eluting Electrode Array
Sorry, in progress, not accepting new patients
An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
Los Angeles, California and other locations
Our lead scientists for Hearing Loss research studies include Akira Ishiyama.
Last updated: